Lonza has announced an expansion to its PyroTec® PRO Automated Robotic Solution for endotoxin testing. The new PyroWave® Reader add-on has been designed specifically for use with the sustainable PyroGene® Recombinant Factor C Assay.

FairJourney Biologics S.A and IONTAS Limited have announced a collaboration with argenx to harness IONTAS’ proprietary mammalian display technology. The goal of the collaboration is to explore diverse panels of novel antibody candidates, with the potential to advance select candidates into the argenx discovery pipeline.

SGD Pharma announces the continued expansion of its Ready-to-Use (RTU) Sterinity molded glass vial platform with the introduction of market-first amber glass 50ml volume option.

2021 marks the 20th anniversary of Lonza’s Nucleofector™ Technology, the industry’s leading non-viral cell transfection method, which has been cited more than 10,000 times, including in research by two Nobel Laureates.

HORIBA UK Ltd, Medical announces that the latest webinar in its new educational webinar series will focus on “An introduction to morphology”. Scheduled for Thursday 15th April 2021 from 11:00 to 12:00 BST, Andrew Fisher FIBMS MSc, Technical Specialist at HORIBA Medical, will present on the basics of blood cell morphology.

BioChromato Inc. has published an interview with the Institute of Analytical Sciences, Faculty of Pharmaceutical Sciences at the University of Fukuoka that explains how a Smart Evaporator C10 has enabled them to concentrate amino acids, without denaturation, such that they can be detected by LC/MS/MS.

Laboratories performing water testing can now benefit from a new, validated application workflow using ion chromatography-tandem mass spectrometry (IC-MS/MS) to achieve haloacetic acid (HAA) analysis in drinking water in accordance with the U.S. Environmental Protection Agency Method 557.

The United States Pharmacopeia will release the new method USP <922> in May 2021, which will outline recommendations for the determination of water activity.

Four additional variants have been added to Eppendorf’s line-up of Move It® adjustable tip spacing pipettes.

Mologic has announced that its rapid antigen self-test for COVID-19 has been selected by the Rapid Acceleration of Diagnostics initiative launched by the U.S. National Institutes of Health. The initiative aims to speed innovation in the development, commercialization, and implementation of technologies for COVID-19 testing.